article · The Lancet Global Health

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda

Eve Nakabembe
Alexander Amone
Bahaa Abu-Raya
Liberty Cantrell
Stephen Taylor
Paul T. Heath
Olivia F. Hunter
Valerie Tusubira
Mary Kyohere
Melanie Greenland
Louisa Dixon
Philippa Musoke
Musa Sekikubo
Manish Sadarangani
Andrew Gorringe
Nick Andrews
E. Lesné
Rachel Halkerston
Annettee Nakimuli
Esther Imede
Nikki Mcstraw
Kyle Amaral
Kirsty Le Doaré

20242 citationsOpen accessMakerere University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Medical Research Council Joint Clinical Trials, Canadian Institutes of Health Research, and British Columbia Children's Hospital Research Institute.

Research topics

Bacterial Infections and Vaccines
SARS-CoV-2 and COVID-19 Research
Pneumonia and Respiratory Infections

Sustainable Development Goals

5Gender Equality

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s2214-109x(24)00409-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.